×
About 9,055 results

ALLMedicine™ HDL Cholesterol Center

Research & Reviews  2,650 results

Effect of a Multi-Strain Probiotic Supplement on Gastrointestinal Symptoms and Serum Bi...
https://doi.org/10.3390/ijerph19159363
International Journal of Environmental Research and Publi... Smarkusz-Zarzecka J, Ostrowska L et. al.

Aug 13th, 2022 - As many as 70% of athletes who practice endurance sports report experiencing gastrointestinal (GI) symptoms, such as abdominal pain, intestinal gurgling or splashing (borborygmus), diarrhea or the presence of blood in the stool, that occur during ...

Determinants of metabolic syndrome among patients attending diabetes clinics in two sub...
https://doi.org/10.1186/s12872-022-02805-4
BMC Cardiovascular Disorders; Abagre TA, Bandoh DA et. al.

Aug 11th, 2022 - Over 70% of individuals with type 2 diabetes mellitus (T2DM) may have metabolic syndrome in sub-Saharan Africa. Evidence about the prevalence, clustering, and determinants of metabolic syndrome components is needed to guide the implementation of i...

The oxytocin signalling gene pathway contributes to the association between loneliness ...
https://doi.org/10.1016/j.psyneuen.2022.105875
Psychoneuroendocrinology Winterton A, Bettella F et. al.

Aug 9th, 2022 - Increasing evidence has shown adverse effects of loneliness on cardiometabolic health. The neuromodulator and hormone oxytocin has traditionally been linked with social cognition and behaviour. However, recent implications of the oxytocin system i...

Are all fibers created equal with respect to lipid lowering? Comparing the effect of vi...
https://doi.org/10.1017/S0007114522002355
The British Journal of Nutrition; Jovanovski E, Nguyen M et. al.

Aug 6th, 2022 - Although compelling evidence from observational studies supports a positive association between consumption of cereal fiber and cardiovascular disease (CVD) risk reduction, randomized clinical trials (RCT)s often target viscous fiber type as the p...

Supplementation With PUFA´s in Obese Children
https://clinicaltrials.gov/ct2/show/NCT05488223

Aug 4th, 2022 - Specific objectives To compare between the study groups, the concentrations of glucose, insulin and HOMA-IR Index, at baseline, at the end of supplementation with PUFA ω-3 and PUFA ω-9 (3 months) and 2 months after supplementation. the supplementa...

see more →

Drugs  37 results see all →

Clinicaltrials.gov  276 results

Supplementation With PUFA´s in Obese Children
https://clinicaltrials.gov/ct2/show/NCT05488223

Aug 4th, 2022 - Specific objectives To compare between the study groups, the concentrations of glucose, insulin and HOMA-IR Index, at baseline, at the end of supplementation with PUFA ω-3 and PUFA ω-9 (3 months) and 2 months after supplementation. the supplementa...

Supplements, Placebo, or Rosuvastatin Study
https://clinicaltrials.gov/ct2/show/NCT04846231

Aug 2nd, 2022 - Few well-controlled trials have studied the LDL-lowering effects of dozens of marketed "cholesterol health" dietary supplements. Prior research suggests most U.S. consumers believe cholesterol health supplements are safer than statins, and a major...

More Fresh Fruit and Vegetable Prescription Program for Families With Type 2 Diabetes Mellitus
https://clinicaltrials.gov/ct2/show/NCT05138432

Jul 26th, 2022 - Participants upon enrollment will be randomized into two groups, either to immediately receive nutrition incentive vouchers for 12 months (intervention group) or to receive nutrition incentive vouchers for 12 months after a 6-month delay (delayed-...

Intra-individual Real Life Effects of Cocoa Flavanols on Blood Pressure and Arterial Stiffness
https://clinicaltrials.gov/ct2/show/NCT05446818

Jul 7th, 2022 - Background: Very controlled dietary intervention studies support that individual polyphenol rich foods and isolated polyphenols can increase endothelial function and HDL cholesterol and decrease blood pressure, arterial stiffness, and LDL choleste...

Microvascular Dysfunction in Obesity
https://clinicaltrials.gov/ct2/show/NCT04087655

Jun 14th, 2022 - Twenty-five sedentary class 2 and above obese [body mass index (BMI) >35 kg/m2, waist circumference >40 inches (men) or >35 inches (women)] men and women (18-45 yrs) will participate in these experiments. Individuals under 18 years of age will not...

see more →

News  649 results

Metabolic syndrome raises dementia risk in under-60s
https://www.mdedge.com/endocrinology/article/256528/lipid-disorders/metabolic-syndrome-raises-dementia-risk-under-60s
Richard Mark Kirkner

Jul 27th, 2022 - The more components of metabolic syndrome a person has in midlife seems to raise their risk of dementia, although that relationship seems to go away after age 70, a post hoc analysis of data from a major European cohort study has found. A team of.

Metabolic Syndrome Raises Dementia Risk in Under-60s
https://www.medscape.com/viewarticle/978135

Jul 27th, 2022 - The more components of metabolic syndrome a person has in midlife seems to raise their risk of dementia, although that relationship seems to go away after age 70, a post hoc analysis of data from a major European cohort study has found. A team of ...

Study provides consensus on lab monitoring during isotretinoin therapy
https://www.mdedge.com/dermatology/article/255673/acne/study-provides-consensus-lab-monitoring-during-isotretinoin-therapy
Doug Brunk

Jun 23rd, 2022 - For generally healthy patients taking isotretinoin for acne and who have no underlying abnormalities or preexisting conditions that warrant further examination, it is sufficient to test ALT and triglycerides once at baseline, ideally within a mont.

Study Provides Consensus on Lab Monitoring in Patients Treated With Isotretinoin
https://www.medscape.com/viewarticle/976116

Jun 23rd, 2022 - For generally healthy patients taking isotretinoin for acne and who have no underlying abnormalities or preexisting conditions that warrant further examination, it is sufficient to test ALT and triglycerides once at baseline, ideally within a mont...

The Best Statins to Lower Non-HDL Cholesterol in Diabetes?
https://www.medscape.com/viewarticle/972109

Apr 13th, 2022 - A network meta-analysis of 42 clinical trials concludes that rosuvastatin, simvastatin, and atorvastatin are the statins most effective at lowering non-high-density-lipoprotein cholesterol (non-HDL-C) in people with diabetes and at risk for cardio...

see more →

Patient Education  10 results see all →